Global X Health Care Covered Call & Growth ETF
HYLG
New York Stock Exchange Arca- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 605 Third Avenue, 43rd Floor New York NY United States of America 10158
- IPO Date
- Nov 23, 2022
- Similar Companies
- Business
- Global X Health Care Covered Call & Growth ETF (HYLG) is an exchange-traded fund that seeks to provide investment results corresponding generally to the price and yield performance, before fees and expenses, of the Cboe S&P Health Care Select Sector Half BuyWrite Index. The fund employs a covered call strategy, holding a portfolio of securities from the S&P Health Care Select Sector Index, including the Health Care Select Sector SPDR Fund, and writing one-month at-the-money call options on approximately 50% of the portfolio value to generate income while retaining partial upside potential from healthcare sector growth. It offers monthly distributions, with a trailing 12-month distribution rate of 5.24%, a net expense ratio of 0.60%, and total net assets of $3.44 million as of the latest reporting. HYLG targets investors seeking income and growth exposure to the U.S. healthcare industry, encompassing large-cap growth and value stocks in pharmaceuticals, biotechnology, health care equipment, and services; the fund is non-diversified and concentrates risk in this sector, which faces regulatory, political, and economic sensitivities. Launched on November 21, 2022, and listed on NYSE Arca, the ETF operates principally in the United States under the management of Global X Management Company LLC, based in New York. In a major recent development, Global X announced on January 24, 2025, the termination and liquidation of HYLG, with trading ceasing on February 14, 2025, and final liquidation on or about February 21, 2025, returning cash proceeds net of costs to shareholders; this action was part of broader product rationalization representing less than 0.1% of the firm's $50 billion AUM, amid ongoing platform evolution including new ETF launches.